BioLineRx's BL-8040 Receives Orphan Drug Designation for Treatment of AML

News   Sep 10, 2013

 
BioLineRx's BL-8040 Receives Orphan Drug Designation for Treatment of AML
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE